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ABSTRACT 
This study highlights the possible implication of NPPA (natriuretic peptide precursor A) gene 
in the etiology of Long QT syndrome (LQTS) by population-based as well as familial study. 
Three SNPs of NPPA - C-664G, C1363A and T1766C were examined by molecular analyses 
in LQTS, controls and first degree relatives (FDRs). This study revealed a possible associa-
tion of 1364 C>A SNP ‘C’ allele with LQTS (p = 0.0013). All three SNPs were in tight link-
age disequilibrium. The familial study highlights the association of NPPA SNP with cLQTS 
and implicating it as a potential biomarker in South Indian population. 
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INTRODUCTION 
Long QT syndrome (LQTS) includes a 
group of rare inherited diseases caused by 
cardiac ion channel gene mutations, resulting 
in prolonged QT due to ventricular repolari-
zation and polymorphic ventricular tachy-
cardia (torsade de pointes) (Kapetanopoulos 
et al., 2006). Congenital LQTS causes sud-
den death in young people and is mostly fa-
milial (Hunter et al., 2008). Genotype–
phenotype study of LQTS emphasizes high 
risk for first cardiac events during adoles-
cence (Moss, 1998). 
The heart as an endocrine organ secretes 
the cardiac hormones atrial natriuretic pep-
tide (ANP) and brain natriuretic peptide 
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(BNP) (Cameron and Ellmers, 2003). Atrial 
natriuretic peptide is a 28–amino acid circu-
lating hormone with natriuretic, vasorelax-
ant, antihypertrophic, and antifibrotic proper-
ties (Francia et al., 2013; Bonow 1996). It is 
well represented in the cerebral areas in-
volved in cardiovascular regulation (Rubattu 
et al., 1999). 
Substantial modifications in ANP gene 
expression have been shown to occur during 
the dramatic circulatory changes that take 
place during the perinatal period (Ernest et 
al., 1998). In both human and ovine fetal 
ventricles, ANP mRNA is considerably 
higher than in adult ventricles and tends to 
decrease with gestational age. In addition to 
cell growth, ANP modulates inhibition of 
vascular smooth muscle proliferation, cardi-
ac hypertrophy and induction of apoptosis in 
cultured cardiac myocytes (Cameron and 
Ellmers, 2003). The developmental natriuret-
ic peptide precursor A (NPPA) gene expres-
sion pattern has served to gain an insight into 
the transcriptional program governing cardi-
ac chamber development (Houweling et al., 
2005). Increased ANP expression has been 
implicated as a marker in embryonic gene 
program induction during the development 
of ventricular hypertrophy (Rubattu et al., 
1999; Cameron and Ellmers, 2003). 
The NPPA gene, localized to 1p36.2 re-
gion, encodes the precursor of ANP, a 2kb 
gene composed of 3 exons (Lynch et al., 
2009). Polymorphisms of NPPA have been 
associated with cardiovascular disease, hy-
pertension, diabetic nephropathy, atrial fi-
brillation and ischemic stroke (Lynch et al., 
2009; Francia et al., 2013). To date, no pro-
spective genetic-epidemiological data is 
available with regards to the NPPA poly-
morphisms and Long QT syndrome. There-
fore, three SNPs of NPPA - a promoter SNP 
C-664G, an intronic SNP C1363A and an 
exonic SNP T1766C were analysed for the 
possible associations with LQTS in compari-
son to controls and first degree relatives 
(FDRs). 
 
METHODOLOGY 
Study subjects 
Blood samples were collected for molec-
ular and genetic analyses from confirmed 45 
LQTS probands and 69 first degree relatives 
referred to Care Hospitals, Hyderabad, Sri 
Jayadeva Institute of Cardiovascular Science 
and Research, Bangalore, Institute of Mater-
nal and Child Health, Calicut Medical Col-
lege, Calicut and Krishna Institute of Medi-
cal Sciences, Hyderabad. The QTc of the 
LQTS patients and their FDRs was con-
firmed by electrocardiogram. LQTS patients 
with prolonged QTc with/without syncope 
and family history of sudden cardiac death 
were included in the study. Available first 
degree relatives of the LQTS probands 
(with/without any history of cardiovascular 
disease) were also included. This study has 
been approved by the Institutional Ethics 
Committee, Department of Genetics, Osma-
nia University, Hyderabad and informed 
written consent was obtained from the pro-
bands and their available family members. 
Blood samples from 150 controls (75 M: 75 
F), without any history of cardiovascular or 
systemic conditions, was collected from Os-
mania General Hospital, Hyderabad for 
comparative analysis. 
 
Molecular analyses 
Genomic DNA was isolated from periph-
eral blood samples by standard protocols in 
150 controls, 45 probands and their family 
members. For genotyping of NPPA gene 
SNPs [C-664G, C1364A (Hpa II), T1766C 
(Sca I)], PCR-RFLP protocol by Kato et al 
(2000) was followed. The digested products 
were later checked on 10 % native PAGE gel 
followed by silver staining for genotyping of 
these polymorphisms. 
 
Statistical analysis 
Fisher's exact test and odds risk estimate 
were computed for possible genotype associ-
ation with LQTS. Interactive SNPs were 
analyzed by means of logistic regression 
(OR) to determine the significance of risk 
genotypes at 95 % confidence interval (CI) 
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followed by haplotype frequency computa-
tion by the EM algorithm using SNPstat 
software (Sole et al., 2006). Linkage disequi-
librium was inferred by Haploview software 
(Barrett et al., 2005). Hapmap was also cre-
ated to compare allelic frequencies with dif-
ferent populations from the International 
Hapmap project. 
 
In-silico analysis 
In-silico analysis was carried out to ex-
amine the influence of polymorphism in 
promoter region for effective transcription 
factor binding by “TFSEARCH" 
(http://www.cbrc.jp/papia/), mRNA second-
ary structure changes 
(http://rna.tbi.univie.ac.at/cgi-bin/RNAfold.cgi) 
(Lorenz et al., 2011), splice site changes 
(www.cbs.dtu.dk/services/NetGene2/) (Hebs-
gaard et al., 1996) and possible binding site 
variations for SnRNP’s involved in spliceo-
some formation (http://sfmap.technion.ac.il/) 
(Paz et al., 2010), protein secondary struc-
ture (http://bioinf.cs.ucl.ac.uk/psipred/) 
(Buchan et al., 2013) were also elucidated.  
 
RESULTS 
Molecular analysis 
PCR-RFLP analysis was carried out for 
NPPA genotyping on 150 controls, 45 LQTS 
patients and 69 first degree relatives (FDR) 
of LQTS patients. Interestingly, in case of -
664 C>G and 1766 T>C SNPs, only ‘CC’ 
and ‘TT’ genotypes respectively were identi-
fied. Similarly, for 1364 C>A polymor-
phism, only CC and CA genotypes were ob-
served. 
 
Statistical analysis 
Genotypic and allelic frequency distribu-
tion of NPPA polymorphisms was calculated 
for controls, patients and FDRs (Table 1). 
‘CC’ genotypic frequency in LQTS patients 
was two-fold (20 %) and three-fold in FDRs 
(28 %) when compared to controls (10 %). 
Similarly, allelic frequency was also found 
to be higher in LQTS patients (0.6) and 
FDRs (0.64) than controls (0.55) thus, indi-
cating a possible association of ‘C’ allele 
with LQTS. 
Odds risk estimates was computed for 
LQTS and FDRs in comparison to controls 
(Table 2). The odds ratios were found to be 
significant with respect to ‘CA’ genotype 
when FDRs were compared to controls [OR-
0.29 (0.14-0.62), p = 0.0013] whereas the 
other comparisons did not reveal any signifi-
cant values.  
 
Haplotype and linkage disequilibrium (LD) 
analysis 
Haplotype frequencies for the various al-
lelic combinations of the three polymor-
phisms (NPPA -664 C>G, 1364 C>A and 
1766 T>C polymorphisms) were computed 
for their possible association with LQTS 
(Table 3). In continuation with the above re-
sults, the CCT haplotype frequency was 
higher in patient group (0.6) and FDRs 
(0.64) compared to controls (0.55) which in-
dicates susceptibility of this haplotype to 
LQTS. Correspondingly, the ACT haplotype 
was found to confer protection (p = 0.0014). 
A pair-wise comparison of the three pol-
ymorphisms, depicting the LD measures was 
carried out. Significant D’ values were ob-
served for all the combinations i.e -664 C>G 
and 1364 C>A SNPs (D’= 0.96), -664C>G 
and 1766 T>C (D’= 0.96) and 1364 C>A and 
1766 T>C (D’= 0.98), indicating a 
strong/tight linkage disequilibrium between 
the SNPs.  
 
 
Table 1: Genotypic and allelic frequency distribution of the 3 polymorphisms of NPPA in controls, 
LQTS patients and FDRs 
SNP Genotype Controls n (%) LQTS n (%) FDR n (%) Allele Controls LQTS FDR 
C-664G CC 150(100) 45(100) 69(100) C 1 1 1 
T1766C TT 150(100) 45(100) 69(100) T 1 1 1 
C1364A CC CA 
15 (10) 
135 (90) 
9 (20) 
36 (80) 
19(28) 
50(72) 
C 
A 
0.55 
0.45 
0.6 
0.4 
0.64 
0.36 
EXCLI Journal 2014;13:834-842 – ISSN 1611-2156 
Received: June 06, 2014, accepted: July 29, 2014, published: August 15, 2014 
 
 
837 
Table 2: Odds risk estimates for the C1364A polymorphisms (p < 0.05) 
 Genotype OR (95 % CI) p value 
Ctrls vs LQTS 
CC 1.00 
0.08 
CA 0.44 (0.18-1.10) 
C vs A 0.81 (0.21-3.06) 0.76 
Ctrls vs FDRs 
CC 1.00 
0.0013 
CA 0.29 (0.14-0.62) 
C vs A 0.68 (0.38-1.21) 0.19 
FDRs vs LQTS 
CC 1.00 
0.36 
CA 1.52 (0.62-3.74) 
C vs A 0.84 (0.47-1.49) 0.56 
 
Table 3: Haplotype frequencies of the 3 polymorphisms in controls and LQTS groups (p < 0.05) 
 Haplotype Haplotype frequency Odds Ratio (95 % CI) p 
  Controls LQTS   
Ctrls vs 
LQTS 
CCT 0.55 0.6 1.00 - 
ACT 0.45 0.4 0.45 (0.18-1.11) 0.083 
  Controls FDRs   
Ctrls vs 
FDRs 
CCT 0.55 0.64 1.00  
ACT 0.45 0.36 0.29 (0.14-0.61) 0.0014 
  FDRs LQTS   
FDRs vs 
LQTS 
CCT 0.64 0.6 1.00  
ACT 0.36 0.4 1.48 (0.6-3.65) 0.4 
 
 
 
In-silico analysis 
The NPPA -664 C>G promoter polymor-
phism leads to the creation of a new binding 
site for transcription regulators ADR1 [alco-
hol dehydrogenase (ADH) II synthesis regu-
lator] which may influence the dysregulation 
of transcription resulting in a truncated pro-
tein. 
Intronic SNP 1364 C>A, increases free 
energy from -110 Kcal/mol to -108 Kcal/mol 
leading to a decrease in thermodynamic sta-
bility of mRNA secondary structure. The ac-
ceptor splice site at 133rd position was also 
affected (confidence value changes from 
0.17 to 0.07). The polymorphism seems to 
affect the binding sites for exonic splicing si-
lencers – hnRNPA1, hnRNPA2B1, hnRNPF, 
hnRNPH1 and exonic splicing enhancers - 
9G8 and Tra2beta. These modifications fur-
ther may influence the downstream signal-
ling finally affecting ANP peptide synthesis. 
Exonic 1766 T>C polymorphism located 
within exon 3 results in a change from a stop 
codon to an arginine amino acid. Protein 
secondary structure prediction revealed an 
increase in helix length and coils. The ANP 
protein folding maybe influenced by this 
SNP as a basic arginine is added to the neu-
tral tyrosine N-terminal of ANP. 
 
Hapmap 
Hapmap created to compare allelic fre-
quencies across populations in -664 C>G 
SNP shows a higher ‘C’ allele frequency in 
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all the reported populations. With respect to 
1364 C>A polymorphism, the ‘A’ allele was 
found to be higher in the South Indian popu-
lation only adding to the genetic diversity. In 
case of 1766 T>C SNP, ‘C’ allele frequency 
was found to be variable in all populations 
(Figure 1). 
 
Genotype-phenotype correlation 
The ‘CC’ genotype of 1364 C>A SNP 
was observed only in nine LQTS patients. 
Since, the presence of ‘C’ allele confers a 
risk to LQTS, the clinical features of these 9 
LQTS patients expressing ‘CC’ genotype 
were examined to establish genotype-
phenotype correlation with the important 
clinical features of LQTS i.e syncope, 
consanguinity, family history of sudden 
death and deafness. Of the nine LQTS pa-
tients with ‘CC’ genotype, 77.7 % were 
cLQTS and predominantly females. It is also 
observed that 66.6 % exhibited parental con-
sanguinity over generations, 44.4 % revealed 
a history of sudden deaths and 55.5 % had a 
history of syncope clearly establishing the 
susceptible allele ‘C’ in the etiopathogenesis 
of cLQTS in families (Table 4). 
 
Family study 
Three families revealed quite interesting 
results with respect to 1364 C>A SNP 
wherein the CC genotype was found in the 
proband, parents and siblings (Table 5). 
Figure 1: Hapmap of NPPA polymorphisms 
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Table 4: Clinical characteristics of 9 LQTS patients exhibiting CC genotype of NPPA 1364C>A poly-
morphism 
cLQTS n(%) Females n (%) 
Deafness  
n (%) 
F/h Sudden death 
n (%) 
Consanguinity 
n (%) 
Syncope 
n (%) 
7 (77.7) 7 (77.7) 1 (11.1) 4 (44.4) 6 (66.6) 5 (55.5) 
 
Table 5: Comparison of characteristics in three LQTS families with ‘CC’ genotype of NPPA 1364 C>A 
SNP 
 Family 1 Family 2 Family 3 
CC genotype 
subjects 
Proband  
Mother (also cLQTS 
patient) 
Proband (cLQTS) 
Father 
Mother 
Sibling  
Proband  
Mother (also cLQTS 
patient) 
Sibling 
Maternal uncle (mother’s 
sibling) 
Deafness in 
proband Present - - 
Consanguinity No Present No 
Syncope in 
proband 
Yes Yes 
Father and sibling also 
exhibited H/o syncope 
Yes 
 
 
 
Both proband and his mother in family-1 
exhibited the ‘CC’ genotype. Family-3 
revealed a similar observation in the 
proband, his mother, sibling and maternal 
uncle.  Family-2 presented both parents and 
sibling of proband with’CC’ genotype and 
this family had a history of syncope (most 
significant symptom of LQTS) in father and 
sibling. All the families revealed cLQTS 
apart from exhibiting consanguinity and 
syncope as common features. The presence 
of 1364 CC genotype in three probands and 
their parents (with LQTS or h/o syncope) 
may possibly implicate the developmental 
gene NPPA in the etiology of LQTS 
especially cLQTS which is also corroborated 
with the above findings. 
 
DISCUSSION 
This study highlights the possible impli-
cation of NPPA gene in the etiology of Long 
QT syndrome by population-based as well as 
family study. Three polymorphisms (-
664C>G, 1364 C>A, 1766T>C) have been 
considered to establish an association with 
LQTS.  
Genotyping of -664C>G revealed only 
‘CC’ genotype in the present study. Allele 
frequencies were found to vary depending on 
ethnic background as shown in hapmap. In 
accordance with our study, -664 C allele fre-
quency was found to be higher in Japanese 
subjects (Kato et al., 2000). The −G664C 
variant has been described in association 
with early hypertension and left ventricular 
hypertrophy (Francia et al., 2013; Conen et 
al., 2007; Yanmin, 2006).  
1766T>C polymorphisms in this study 
revealed only ‘TT’ genotype. The C allele 
frequency of this polymorphism; which was 
absent in the present study; was 0.26 in 
French whites, 0.11 in Mauritian Indians and 
0.42 in hypertensive and 0.39 in normoten-
sive individuals of black origin attributing to 
the diversity of this polymorphism (Nan-
nipieri et al., 2001). 1766 T>C SNP had no 
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association in American population with 
atrial fibrillation and essential hypertension 
in Xinjiang Kazakhs (Francia et al., 2013; 
Conen et al., 2007, Yanmin, 2006).  
In case of 1364 C>A only ‘CC’ and ‘CA’ 
genotypes were observed. The ‘C’ allele of 
1364 C>A was higher in LQTS patients and 
FDRs indicating its possible role in LQTS 
etiology. 1364 C>A SNP has been shown to 
have an association with hypertension in 
black Africans (Kato et al., 2000). This study 
revealed a possible role of 1364 C allele in 
LQTS etiology. In-silico analysis of intronic 
SNP 1364 C>A predicted its effect on 
mRNA thermodynamic stability; splice site 
and spliceosome factor binding sites which 
may alter the downstream regulation of ANP 
peptide synthesis leading to a possible mal-
function during cardiogenesis thus, playing a 
role in LQTS pathology.  
On considering the LQTS patients with 
homozygous ‘CC’ genotype, our study estab-
lished an association with cLQTS females 
who presented with syncope and consan-
guinity. Such genotype-phenotype correla-
tions can be advantageous in subjecting pa-
tients exhibiting the above parameters to a 
genetic analysis of NPPA polymorphisms 
and in risk stratification of FDRs. This is the 
first study to the best of our knowledge to 
report the phenotypic/diagnostic parameters 
with CC genotype of 1364C>A in LQTS. 
Further, earlier studies have reported an as-
sociation of minor allele of C-664G with in-
creased Left Ventricular (LV) mass index, 
LV posterior wall thickness, LV septal 
thickness and relative wall thickening. Simi-
larly, TT genotype at T1766C was correlated 
with risk to hypertension among those with 
BMI > 85th percentile (Lynch et al., 2009).  
Three families each with two clinically 
affected/symptomatic LQTS probands exhib-
ited CC genotype of 1364 C>A SNP. All 
these probands exhibited cLQTS with a his-
tory of parental consanguinity and syncope. 
Since, the observed probands of this study 
exhibited congenital LQTS, it can be de-
duced that 1364 C>A SNP of NPPA may be 
implicated in the etiology of cLQTS by in-
fluencing cardiogenesis regulation. There-
fore, this NPPA polymorphism can act as a 
potential biomarker for cLQTS and may help 
in risk stratification of family members by 
predictive/genetic testing. 
Further, the higher frequency of ‘CCT’ 
haplotype in LQTS patients may substantiate 
as a potential biomarker in LQTS. This was 
confirmed by a tight LD between –G664C, 
C1364A and T1766C polymorphic loci thus, 
implicating the developmental NPPA gene as 
a potential biomarker. 
 
CONCLUSION 
Our study hypothesizes the possible im-
plication of NPPA 1364 C>A SNP in the eti-
ology of LQTS in South Indian population. 
Since, all the three SNPs are in complete LD, 
NPPA can be a considered a candidate gene 
for biomarker/diagnostics of cLQTS. The 
family study highlights the involvement of 
NPPA 1364 C>A SNP in the etiology of 
LQTS during cardiac organogenesis in the 
embryo. Functional and large population 
studies are warranted to confirm our hypoth-
esis. This is the first family study to the best 
of our knowledge to report the association of 
LQTS with NPPA 1364 C>A polymorphism 
and the possibility to be considered a bi-
omarker for LQTS. 
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